Cargando…
Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future
Patients suffering from rheumatologic diseases are known to have an increased risk for cardiovascular disease (CVD). Although the pathological mechanisms behind this excess risk have been increasingly better understood, there still seems to be a general lack of consensus in early detection and treat...
Autores principales: | Mandel, Anna, Schwarting, Andreas, Cavagna, Lorenzo, Triantafyllias, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279857/ https://www.ncbi.nlm.nih.gov/pubmed/35847825 http://dx.doi.org/10.3389/fmed.2022.820263 |
Ejemplares similares
-
Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review
por: Triantafyllias, Konstantinos, et al.
Publicado: (2023) -
Biotechnological Drugs: The Breakthrough in Autoimmune Rheumatic Conditions
por: Cavagna, Lorenzo, et al.
Publicado: (2014) -
Patients with Rheumatic Diseases do not have an Increased Risk of MRSA Carrier Status
por: Krämer, Judith, et al.
Publicado: (2018) -
NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways—Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases
por: Marinoska, Tatjana, et al.
Publicado: (2023) -
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
por: Basta, Fabio, et al.
Publicado: (2020)